Indiana lawmakers still hoping to adjourn Thursday
Lawmakers are close to a compromise on a work-site guns bill, but remain farther apart on several other issues.
Lawmakers are close to a compromise on a work-site guns bill, but remain farther apart on several other issues.
Police say a couple was robbed at gunpoint Monday night close to the busiest area of Broad Ripple. The incident occurred
near Paxton Avenue and Carrollton, two blocks from Broad Ripple Avenue and one block from College Avenue. According to police,
the two robbers approached the couple from behind, forced them to the ground and stole the woman’s purse and man’s
wallet, both containing cash and credit cards. The victims did not get a good look at the suspects.
General Growth Properties Inc. may favor a risky bid from Brookfield Asset Management Inc. because of that company’s
agreement with William Ackman’s Pershing Square Capital Management LP, creditors said in court documents. Simon Property
Group also has bid to acquire the bankrupt company.
Call it California screamin.’ Indianapolis-based WellPoint Inc. continues to get a steady flow of
bad news coming from the Golden State, which is feeding problems for the health insurer in Washington, D.C. WellPoint CEO
Angela Braly gave an unapologetic defense last week before a congressional committee about her company’s 25-percent
premium hike on individual customers in California. But the next day, California Attorney General Jerry Brown subpoaned documents
from WellPoint and its insurance peers in an investigation into whether their premium increases and claims denials were illegal.
According to Bloomberg News, the investigation was undertaken in response to reports that California insurance providers deny
almost 40 percent of claims. Then on Monday, a consumer watchdog group sued WellPoint for pushing consumers to take coverage
with fewer benefits and higher deductibles, which the lawsuit says violates California law, according to the Associated Press.
On Thursday, President Obama’s top health official, Kathleen Sebelius, wants to see WellPoint and its rivals in her
office to explain their premium hikes. Heavy media attention on premium hikes in states across the country has revived Obama’s
health reform efforts, which WellPoint has opposed since last fall. The only good news for WellPoint came on Wall Street,
where investors are pleased the company is raising its prices faster than medical costs are escalating. WellPoint’s
stock price surged 6 percent last week alone.
The Indiana University Melvin and Bren Simon Cancer Center has named a replacement for former director Stephen
Williams, who died of cancer in February 2009. The center chose Dr. Patrick J. Loehrer Sr., who joined the IU faculty in 1990,
and also will serve as associate dean for cancer research and hold the title HH Gregg Professor of Oncology at the IU School
of Medicine. Loehrer is an internationally recognized researcher and specialist in testicular cancer, gastrointestinal cancer,
and thymoma. His appointment must be approved by university trustes.
Indianapolis-based PDS Biotechnology Corp. won a $1.28 million grant from the National Cancer Institute
to help it complete preclinical testing of an experimental drug aimed at curing infections and cancers caused by human papillomavirus.
The most common cancers caused by the virus are cervical, anal and head and neck cancers. PDS said 400 million people have
the virus, and no existing vaccines offer a cure.
The University of Notre Dame licensed technology developed by one of its professors to Pennsylvania-based
Molecular Targeting Technologies Inc. Financial terms of the deal were not disclosed. The technology, developed by chemistry
prof Bradley Smith, can target dead or dying cells in humans or in bacteria clusters. Such selective sensing could help researchers
see more clearly the effects of treatments on cancers or bacterial infections.
Tax collections for February fell $86 million below a revised December forecast. Revenue is down $166 million in the first
three months since that forecast.
While top prospects were on display at yesterday's NFL Combine in Indianapolis, members of the league's competition
committee were hotly debating a rule that could change the game next year.
General Growth, the bankrupt takeover target of Simon Property Group, aims to confirm a reorganization plan by Oct. 5. In addition, it said it will launch an initial public offering on Friday.
With funding of $12 million over four years, Stan Jones wants to influence states to focus on getting college students to
graduate.
Indianapolis police arrested a Fort Wayne man Saturday after he allegedly used a shoe camera to look up women's dresses
at Castleton Square Mall. David Delagrange, 40, approached several women and placed his foot under their dresses to make recordings,
police say. Delagrange was subdued him with a Taser before being taken into custody. He is charged with voyeurism, resisting
arrest, and child exploitation because one of the victims was believed to be a juvenile.
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
“It will happen to you.” That’s what Joan Didion tells us right up front in “The Year of Magical Thinking,” the one-woman play based
on her memoir of the same name.
The new work was delayed by 16 months because the artist’s New Orleans home and studio were destroyed by Hurricane Katrina.
New claims for unemployment benefits jumped unexpectedly last week, mostly because state agencies processed a backlog of
claims caused by snowstorms the previous week.
A National Collegiate Athletic Association posse will be supplemented by local police officers in search of unlicensed T-shirts
and other memorabilia.
Race car driver Paul Tracy said IndyCar fans need to stand up and let series officials know what they want. Meanwhile, Derek Daly said the open-wheel series has turned its back on a generation of new American drivers.
The Indianapolis-area claims three of the four healthiest counties in the state, but also some of the laggards, according
to a new report by New Jersey-based Robert Wood Johnson Foundation. Hamilton, Hendricks and Boone counties ranked first, second
and fourth, respectively. The rankings were based on such things as death rates, insurance rates, socioeconomic factors and
environmental influences. However, Marion County ranked 80th out of Indiana’s 92 counties. Shelby and Madison counties
also scored poorly, ranking No. 70 and No. 79, respectively.
Most of Indiana’s life sciences business development has occurred in the “golden triangle” that runs from
Bloomington to Indianapolis to Lafayette. But the latest investment by BioCrossroads’ Indiana Seed
Fund shows some potential for cross-state development that breaks out of that mold. South Bend-based Bioscience Vaccines
Inc. has licensed the extracellular matrix technology developed by Cook Biotech in West Lafayette.
With scientific help from the University of Notre Dame, Biosciences Vaccine aims to start a clinical trial
by year’s end. It hopes that combining Cook Biotech’s extracellular matrix with vaccines against tetanus and prostate
cancer will prove more effective than traditional delivery of the medicines. BioCrossroads will commit $400,000 to help the
company’s research.
Indianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing
and distribution operations and creating more than 60 life sciences jobs in the next three years. Founded in 2006, the company
expects to launch a consumer subsidiary in the second quarter to focus on health care products. It plans to begin hiring employees
for both the consumer and medical product divisions beginning in April. Vortek develops and markets medical devices designed
to reduce the risk of hospital infections during surgery.
Indianapolis-based Marcadia Biotech Inc. has launched a Phase 1 clinical trial of its experimental anti-diabetes
drug MAR701. The drug mimics the action of two hormones, glucagon-like peptide and gastric inhibitory peptide. Those proteins
both boost the body’s production of insulin, which is necessary to fight diabetes. Marcadia hopes to market the drug
as a once-a-week medicine to treat Type 2 diabetes.
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.